Pharmgate concludes merger with ProtaTek International, Inc.

Wilmington NC. October 12, 2016

Pharmgate LLC announced today that it has successfully concluded its merger with ProtaTek International, Inc., which will continue to operate as a wholly owned subsidiary. Former ProtaTek board members, Roger Headrick and Dr. Shi-Jun Ma, will be retained on the board of the company. Manufacturing, laboratory, regulatory, accounting and customer service functions will remain in St Paul, Minnesota. The products will be sold and serviced under the Pharmgate Animal Health banner in the USA and Canada, and Pharmgate LLC in international markets.

ProtaTek currently markets a range of biologicals through a network of distributors, and has a pipeline of novel products that will be introduced globally over a number of years. This will significantly enhance Pharmgate’s expanding range of animal health solutions offered to its customers.

At the same time, the company has appointed Dr. Mary Jo Baarsch as Vice President of Biologicals Operations, who will join the team in St. Paul. Dr. Baarsch has an extensive background in vaccine development and commercialization with multinational and boutique animal health and pharmaceutical companies. She holds a PhD from the University of Minnesota and an MBA from the Rensselaer Polytechnic Institute in CT. She will also serve on the company board.

About Pharmgate

Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline and other fermentation compounds, and more recently, the majority owner of Jianliang Veterinary Biologicals, a company manufacturing and supplying vaccines to the domestic market in China.

Contact: Colin Gray +1 910 679 8364


View Labels »


Visit Website »


  • October 12, 2016 Pharmgate concludes merger with ProtaTek International, Inc.

    September 15, 2016 Pharmgate announces agreement to acquire ProtaTek International, Inc.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

    August 1, 2016 - Pharmgate announces new appointments.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

  • November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

    August 13, 2015 - Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina.

  • March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

    August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.

  • August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce...

    August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.

  • November 3, 2014 - Pharmgate concludes acquisition of Pennfield Animal Health

    October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.


Pharmgate Animal Health LLC
1800 Sir Tyler Drive
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Pharmgate Animal Health Canada, Inc.
5204 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0
Tel: 1-800-465-2450
Fax: 910-679-8368